Results 31 to 40 of about 6,281 (181)

Biochar and Sulphur Enriched Digestate: Utilization of Agriculture Associated Waste Products for Improved Soil Carbon and Nitrogen Content, Microbial Activity, and Plant Growth

open access: yesAgronomy, 2021
A number of agriculture residues may be used either directly or after suitable treatment as amendments to improve soil quality. Such materials include biochar made of agriculture residues, digestate or elemental sulphur obtained from biogas ...
Tereza Hammerschmiedt   +9 more
doaj   +1 more source

Localization of arylsulfatase in Pseudomonas C12B [PDF]

open access: yesApplied and Environmental Microbiology, 1977
Arylsulfatase was released almost completely from intact cells of Pseudomonas C12B after osmotic shock or after treatment with lysozyme. These results suggest that the enzyme is cell wall associated in this soil isolate.
J W, Fitzgerald, J R, George
openaire   +2 more sources

Molecular Basis of Metachromatic Leukodystrophies

open access: yesPediatric Neurology Briefs, 1991
Arylsulfatase A alleles were analyzed in 68 patients with metachromatic leukodystrophy in the Department of Biochemistry II, Georg-August-Universitat Gottingen, Gosslerstr, Gottingen, Germany.
J Gordon Millichap
doaj   +1 more source

Chemical Metabolomics: Chemical Biology Tools for Advanced Metabolism Investigations

open access: yesAngewandte Chemie, Volume 138, Issue 23, 1 June 2026.
The human metabolism has been investigated for several millennia. The metabolome is known for a high complexity due to a large number of different metabolites that are present at different concentrations. Metabolomics has been developed as a field to investigate the entire human metabolome and to elucidate disease development mechanisms.
Alejandro Torregrosa‐Chinillach   +4 more
wiley   +2 more sources

Central Precocious Puberty in a Child With Metachromatic Leukodystrophy

open access: yesFrontiers in Endocrinology, 2018
Metachromatic leucodystrophy (MLD) is a rare inherited lysosomal disorder caused by reduced activity of the enzyme arylsulfatase A with accumulation of sulfatides in the nervous system.
Gilda Belli   +6 more
doaj   +1 more source

Endogenous melatonin partial metabolic clearance as a potential endogenous marker of CYP1A2 activity

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Cytochrome P450 1A2 (CYP1A2) exhibits substantial interindividual variability, necessitating appropriate phenotyping strategies for personalized pharmacotherapy. This study evaluated endogenous melatonin partial metabolic clearance (CLm(MEL)), calculated from urinary 6‐hydroxymelatonin (6‐O‐MEL) excretion and plasma melatonin (MEL) exposure, as a ...
Akitomo Yokokawa   +5 more
wiley   +1 more source

Enzymatic Activity in Different Crop Succession Systems in the Cerrado Region

open access: yesAgronomy
The enzymatic activity of soil arylsulfatase and β-glucosidase enzymes are biological parameters used to measure the biological activity of soils, an important tool for identifying disturbances in agricultural systems, as they are more sensitive to ...
Vanessa Brenda Souza Chaves   +4 more
doaj   +1 more source

Ocular Manifestation in a Rare Case of Mucopolysaccharidosis VI

open access: yesJournal of Mazandaran University of Medical Sciences, 2021
Mucopolysaccharidosis VI is an inherited autosomal recessive disease that causes glycosaminoglycan deposition in different tissues due to arylsulfatase deficiency that can cause various systemic and ocular manifestations.
Leila Rezaei, Naser Aghaei
doaj  

Comprehensive clinical, biochemical, radiological and genetic analysis of 28 Turkish cases with suspected metachromatic leukodystrophy and their relatives

open access: yesMolecular Genetics and Metabolism Reports, 2020
Metachromatic leukodystrophy (MLD) is a glycosphingolipid storage disease caused by deficiency of the lysosomal enzyme arylsulfatase A (ASA) or its activator protein saposin B. MLD can affect all age groups in severity varying from a severe fatal form to
Faruk Pekgül   +12 more
doaj   +1 more source

Nonclinical comparability studies of recombinant human arylsulfatase A addressing manufacturing process changes. [PDF]

open access: yesPLoS ONE, 2018
Recombinant human arylsulfatase A (rhASA) is in clinical development for the treatment of patients with metachromatic leukodystrophy (MLD). Manufacturing process changes were introduced to improve robustness and efficiency, resulting in higher levels of ...
Teresa Wright   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy